MEREO
LIVE

Serial Number

79189354

Owner

Mereo BioPharma Group Limited

Attorney

Anessa Owen Kramer

Filing Date

May 4, 2016

Add to watchlist:

No watchlists yet
View on USPTO

MEREO Trademark

Serial Number: 79189354 • Registration: 5211334

MEREO is a trademark filed by Mereo BioPharma Group Limited on May 4, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Mereo BioPharma Group Limited

4th Floor
London W1G 0QF , GB

Entity Type: 99

Mereo BioPharma Group Plc (2 trademarks)

4th Floor,

Entity Type: 99

Trademark Details

Filing Date

May 4, 2016

Registration Date

May 30, 2017

Published for Opposition

March 14, 2017

Goods & Services

[ Pharmaceutical and biopharmaceutical preparations and drugs for the treatment of rare and specialist diseases and conditions; pharmaceutical and biopharmaceutical preparations and drugs for the treatment of orphan diseases; pharmaceutical and biopharmaceutical preparations and drugs for the treatment of inflammatory diseases; pharmaceutical and biopharmaceutical preparations and drugs for the treatment of respiratory disorders; pharmaceutical and biopharmaceutical preparations and drugs for the treatment of chronic obstructive pulmonary disease (COPD); pharmaceutical and biopharmaceutical preparations and drugs for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD); pharmaceutical and biopharmaceutical preparations and drugs, namely, bronchodilators and anti-asthma preparations; pharmaceutical and biopharmaceutical preparations and drugs for the treatment of osteogenesis imperfecta (OI) (brittle bone syndrome); pharmaceutical and biopharmaceutical preparations and drugs to improve bone density and treat bone weakness; pharmaceutical and biopharmaceutical preparations and drugs for the treatment of obesity; pharmaceutical and biopharmaceutical preparations and drugs for normalising testosterone levels; pharmaceutical and biopharmaceutical preparations and drugs, namely, aromatase inhibitors (AIs); pharmaceutical and biopharmaceutical preparations and drugs for treating hypogonadotrophic hypogonadism (HH); antibiotics ]

Scientific research and design relating thereto; industrial analysis and research services in the field of medicine and disease; medical and pharmaceutical research services; scientific research for medical purposes; research, inspection, testing, development and evaluation of the pharmaceutical products of others in the field of medicine and disease; research, inspection, testing, development and evaluation of pharmaceutical [ and veterinary ] preparations, products and drugs; conducting clinical trials for others; information, advisory and consultancy services relating to all the aforesaid services

Filing History

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
May 30, 2026 REM4
INTERNATIONAL REGISTRATION RENEWED
Apr 16, 2026 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Feb 19, 2026 NREP
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Aug 11, 2025 LIMN
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Dec 6, 2024 RHRD
PARTIAL INVALIDATION PROCESSED BY THE IB
Nov 29, 2024 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Oct 22, 2024 INPS
INVALIDATION PROCESSED
Oct 22, 2024 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 6, 2024 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Feb 5, 2024 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Feb 5, 2024 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 29, 2024 APRE
TEAS SECTION 71 & 15 RECEIVED
May 30, 2023 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 30, 2022 REM3
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jan 28, 2019 LIMN
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Jan 17, 2019 RHRD
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 28, 2017 FINO
CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 13, 2017 ADCH
FINAL DISPOSITION NOTICE SENT TO IB
Sep 8, 2017 FICS
FINAL DISPOSITION PROCESSED
Sep 8, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 30, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
May 30, 2017 R.PR
PUBLISHED FOR OPPOSITION
Mar 14, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Mar 10, 2017 GPNX
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 3, 2017 TCCA
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 22, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 22, 2017 OP2R
NOTICE OF PUBLICATION
Feb 22, 2017 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 9, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 20, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 19, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 19, 2017 CRFA
ASSIGNED TO LIE
Jan 18, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 19, 2016 TROA
REFUSAL PROCESSED BY IB
Sep 16, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 30, 2016 RFCS
REFUSAL PROCESSED BY MPU
Aug 30, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 30, 2016 RFCR
NON-FINAL ACTION WRITTEN
Aug 29, 2016 CNRT
ASSIGNED TO EXAMINER
Aug 20, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 26, 2016 MAFR
APPLICATION FILING RECEIPT MAILED
Jul 26, 2016 MAFR
APPLICATION FILING RECEIPT MAILED
Jul 26, 2016 MAFR
APPLICATION FILING RECEIPT MAILED
Jul 26, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 22, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 21, 2016 REPR